Alterola Biotech, Inc.
ABTI · OTC
3/31/2023 | 3/31/2022 | 9/30/2020 | 9/30/2019 | |
|---|---|---|---|---|
| Market Cap | $35,237 | $169,393 | $83,825 | $142,207 |
| - Cash | $9 | $64 | $0 | $0 |
| + Debt | $1,415 | $164 | $0 | $0 |
| Enterprise Value | $36,643 | $169,493 | $83,825 | $142,207 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$1,697 | -$6,471 | -$251 | -$258 |
| % Margin | – | – | – | – |
| Net Income | -$1,542 | -$6,471 | -$172 | -$259 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.002 | -0.008 | -0.002 | -0.002 |
| % Growth | 77.4% | -460% | 31.8% | – |
| Operating Cash Flow | -$1,040 | $44 | $0 | $0 |
| Capital Expenditures | -$140 | $0 | $0 | $0 |
| Free Cash Flow | -$1,180 | $44 | $0 | $0 |